NVNO's three largest insider shareholders as of September 29, 2026 are Francis Duhay (Director, 2.35K shares), Robert Andrew Berman (Chief Executive Officer, 254 shares), Marc H. Glickman (Svp Chief Medical Officer, 116 shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Francis Duhay | Director | 2,351 | 0 | 2,351 | 83.4% | 14 Sep, 2026 |
| 2 | Robert Andrew Berman | Chief Executive Officer | 254 | 0 | 254 | 9.0% | 19 Dec, 2024 |
| 3 | Marc H. Glickman | Svp Chief Medical Officer | 116 | 0 | 116 | 4.1% | 02 Dec, 2021 |
| 4 | Craig Glynn | Chief Financial Officer | 57 | 0 | 57 | 2.0% | 02 Dec, 2021 |
| 5 | Matthew Jenusaitis | Director | 19 | 0 | 19 | 0.7% | 23 Dec, 2024 |
| 6 | Robert Gray | Director | 13 | 0 | 13 | 0.5% | 02 Jan, 2025 |
| 7 | Sanjay Shrivastava | Director | 11 | 0 | 11 | 0.4% | 26 Dec, 2024 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 11 Jun, 2026 | Francis Duhay | Director | Disposed S | 140 | $10.31 | $1.44K | 2,362 | Direct |
| 12 Mar, 2026 | Francis Duhay | Director | Disposed S | 140 | $11.52 | $1.61K | 2,502 | Direct |
| 16 Dec, 2025 | Hamed Alavi | Chief Technology Officer | Disposed J | 50,000 | $0.00 | $0 | 0 | Direct |
| 16 Dec, 2025 | Robert Andrew Berman | Chief Executive Officer | Disposed J | 200,000 | $0.00 | $0 | 0 | Direct |
| 16 Dec, 2025 | Marc H. Glickman | Svp Chief Medical Officer | Disposed J | 100,000 | $0.00 | $0 | 0 | Direct |
| 11 Dec, 2025 | Sanjay Shrivastava | Director | Acquired A | 135,883 | $0.00 | $0 | 155 | Direct |
| 11 Dec, 2025 | Matthew Jenusaitis | Director | Acquired A | 135,883 | $0.00 | $0 | 155 | Direct |
| 11 Dec, 2025 | Robert Gray | Director | Acquired A | 135,883 | $0.00 | $0 | 155 | Direct |
| 11 Dec, 2025 | Francis Duhay | Director | Acquired A | 135,883 | $0.00 | $0 | 155 | Direct |
| 11 Dec, 2025 | Francis Duhay | Director | Disposed S | 4,900 | $311.17 | $1.52Mn | 106 | Direct |
| 15 Sep, 2025 | Francis Duhay | Director | Disposed S | 4,900 | $726.29 | $3.56Mn | 111 | Direct |
| 19 May, 2025 | Jennifer Bright | Chief Financial Officer | Acquired A | 350,000 | $0.00 | $0 | 400 | Direct |
| 31 Dec, 2024 | Francis Duhay | Director | Acquired P | 81,433 | $2,686.38 | $218.76Mn | 117 | Direct |
| 31 Dec, 2024 | Robert Gray | Director | Acquired P | 3,500 | $2,572.63 | $9.00Mn | 13 | Direct |
| 24 Dec, 2024 | Sanjay Shrivastava | Director | Acquired P | 5,400 | $2,537.63 | $13.70Mn | 11 | Direct |
| 19 Dec, 2024 | Matthew Jenusaitis | Director | Acquired P | 9,620 | $2,213.86 | $21.30Mn | 19 | Direct |
| 18 Dec, 2024 | Sanjay Shrivastava | Director | Acquired A | 19,752 | $0.00 | $0 | 23 | Direct |
| 18 Dec, 2024 | Marc H. Glickman | Svp Chief Medical Officer | Acquired A | 75,000 | $0.00 | $0 | 86 | Direct |
| 18 Dec, 2024 | Matthew Jenusaitis | Director | Acquired A | 19,752 | $0.00 | $0 | 23 | Direct |
| 18 Dec, 2024 | Robert Andrew Berman | Chief Executive Officer | Acquired A | 200,000 | $0.00 | $0 | 229 | Direct |